Families of children who have experienced "transformative" results from fenfluramine during a Melbourne trial say they cannot afford the drug, which costs $60,000 a year, if it is not added to the Pharmaceutical Benefits Scheme. ⌘ Read more
Families of children who have experienced "transformative" results from fenfluramine during a Melbourne trial say they cannot afford the drug, which costs $60,000 a year, if it is not added to the Pharmaceutical Benefits Scheme. ⌘ Read more